About

The Colorado Sickle Cell Treatment and Research Center, established over 40 years ago, and its patient care clinics at the Children's Hospital Colorado and the University of Colorado Hospital on the CU Anschutz Medical Campus is the region's primary source of specialty expertise and facilitation of comprehensive specialty care for both children and adults living with hemoglobinopathies. Basic, clinical and health services research conducted by the Center and its collaborators serves to elucidate the pathophysiology of sickle cell disease, develop and implement treatments and systems of care that prevent or minimize complications and that prolong and improve the quality of life, are supported by funding from the NIH and other Federal agencies, industry, and foundations.  Direct patient care is also provided by our Director Kathryn Hassell, MD for adults at University of Colorado Hospital and by Associate Director Rachelle Nuss, MD for pediatric patients at Children’s Hospital Colorado (CHCO).  Our Transition Program targets 12 to 26-year-olds to facilitate self-advocacy and health system navigation skills as youth move from pediatric- to adult-oriented healthcare.  

Our Mission

  • Provide comprehensive care to all persons with sickle cell disease and other hemoglobinopathies
  • Conduct research to elucidate the pathophysiology of sickle cell disease
  • Develop and implement treatments and systems of care that prevent or minimize complications and that prolong and improve the quality of life

The Center is also committed to providing education about sickle cell disease and other hemoglobin disorders to physicians, nurses, other healthcare providers and trainees, and the community at large.


Comprehensive Care

The key to obtaining optimal outcomes for patients with Sickle Cell Disease is enrollment in a program of specialized comprehensive care provided by a multi-disciplinary team of providers with expertise in Sickle Cell Disease.

  • Comprehensive care includes extensive patient and family education
  • Psychosocial support
  • Periodic medical evaluations to review disease manifestations
  • Document important baseline physical findings and laboratory values
  • Monitor nutrition, growth, development, and educational achievement
  • Detect early signs of organ damage.

In addition, patients are periodically evaluated for specific therapies such as chronic transfusions, Hydroxyurea, or bone marrow transplantation. 

Clinic Contact

 University of Colorado Hospital
Adult Clinic720.848.0300

 Children's Hospital Colorado 
Pediatric Clinic: 720.777.6740     

 

Program Leadership

 Director: Kathryn Hassell, MD

 Associate Director: Rachelle Nuss, MD

 View all Contacts